• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4602591)   Today's Articles (1982)   Subscriber (49368)
For: Antoniadou A, Dupont B. Lipid formulations of amphotericin B: where are we today? J Mycol Med 2005;15:230-8. [DOI: 10.1016/j.mycmed.2005.06.005] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Number Cited by Other Article(s)
1
León-Buitimea A, Garza-Cervantes JA, Gallegos-Alvarado DY, Osorio-Concepción M, Morones-Ramírez JR. Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis. Pathogens 2021;10:pathogens10101303. [PMID: 34684252 PMCID: PMC8539376 DOI: 10.3390/pathogens10101303] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Revised: 10/02/2021] [Accepted: 10/03/2021] [Indexed: 12/23/2022]  Open
2
Baron HR, Stevenson BC, Phalen DN. Inconsistent efficacy of water-soluble amphotericin B for the treatment of Macrorhabdus ornithogaster in a budgerigar (Melopsittacus undulatus) aviary. Aust Vet J 2020;98:333-337. [PMID: 32115681 DOI: 10.1111/avj.12936] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2019] [Revised: 01/23/2020] [Accepted: 02/14/2020] [Indexed: 01/13/2023]
3
Design, development and evaluation of mannosylated oral Amphotericin B nanoparticles for anti-leishmanial therapy: Oral kinetics and macrophage uptake studies. J Drug Deliv Sci Technol 2018. [DOI: 10.1016/j.jddst.2017.10.013] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
4
Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp. Pathogens 2017;6:pathogens6040062. [PMID: 29194382 PMCID: PMC5750586 DOI: 10.3390/pathogens6040062] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2017] [Revised: 11/20/2017] [Accepted: 11/29/2017] [Indexed: 11/29/2022]  Open
5
Muszewska A, Pawłowska J, Krzyściak P. Biology, systematics, and clinical manifestations of Zygomycota infections. Eur J Clin Microbiol Infect Dis 2014;33:1273-87. [PMID: 24615580 PMCID: PMC4077243 DOI: 10.1007/s10096-014-2076-0] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2013] [Accepted: 01/31/2014] [Indexed: 01/13/2023]
6
Zu Y, Sun W, Zhao X, Wang W, Li Y, Ge Y, Liu Y, Wang K. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation. Eur J Pharm Sci 2013;53:109-17. [PMID: 24345795 DOI: 10.1016/j.ejps.2013.12.005] [Citation(s) in RCA: 63] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2013] [Revised: 11/07/2013] [Accepted: 12/08/2013] [Indexed: 11/19/2022]
7
Strategies for the design of orally bioavailable antileishmanial treatments. Int J Pharm 2013;454:539-52. [PMID: 23871737 DOI: 10.1016/j.ijpharm.2013.07.035] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2013] [Revised: 07/08/2013] [Accepted: 07/10/2013] [Indexed: 12/21/2022]
8
Pham TTH, Barratt G, Michel JP, Loiseau PM, Saint-Pierre-Chazalet M. Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B-miltefosine-loaded nanocochleates. Colloids Surf B Biointerfaces 2013;106:224-33. [PMID: 23434716 DOI: 10.1016/j.colsurfb.2013.01.041] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2012] [Accepted: 01/21/2013] [Indexed: 11/15/2022]
9
Stevens DA. Advances in systemic antifungal therapy. Clin Dermatol 2012;30:657-61. [DOI: 10.1016/j.clindermatol.2011.09.018] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
10
PLGA nanoparticles and nanosuspensions with amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome. J Control Release 2012;161:795-803. [DOI: 10.1016/j.jconrel.2012.05.037] [Citation(s) in RCA: 111] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2012] [Revised: 05/16/2012] [Accepted: 05/20/2012] [Indexed: 11/23/2022]
11
Nasr M, Nawaz S, Elhissi A. Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization. Int J Pharm 2012;436:611-6. [PMID: 22842623 DOI: 10.1016/j.ijpharm.2012.07.028] [Citation(s) in RCA: 62] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2012] [Revised: 07/14/2012] [Accepted: 07/17/2012] [Indexed: 11/26/2022]
12
Nair AG, Fudnawala V, Arjundas D, Noronha VO, Malathi J, Therese L, Gandhi RA. Isolated Unilateral Infiltrative Cryptococcal Optic Neuropathy in an Immunocompetent Individual. Neuroophthalmology 2010. [DOI: 10.3109/01658107.2010.494762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
13
Craddock C, Anson J, Chu P, Dodgson A, Duncan N, Gomez C, Mehta J, Sadullah S, Subudhi C, Yin JL. Best practice guidelines for the management of adverse events associated with amphotericin B lipid complex. Expert Opin Drug Saf 2009;9:139-47. [DOI: 10.1517/14740330903418430] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
14
Jung SH, Lim DH, Jung SH, Lee JE, Jeong KS, Seong H, Shin BC. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics. Eur J Pharm Sci 2009;37:313-20. [DOI: 10.1016/j.ejps.2009.02.021] [Citation(s) in RCA: 82] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2008] [Revised: 02/16/2009] [Accepted: 02/25/2009] [Indexed: 11/24/2022]
15
Cagatay AA, Cosan F, Karadeniz A, Besısık SK, Ozsut H, Nalcaci M, Pekcelen Y, Eraksoy H, Dincol G, Calangu S. The clinical and pharmacoeconomic analysis of invasive aspergillosis in adult patients with haematological diseases. Mycoses 2008;51:328-35. [DOI: 10.1111/j.1439-0507.2007.01483.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
16
Baginski M, Czub J, Sternal K. Interaction of amphotericin B and its selected derivatives with membranes: molecular modeling studies. CHEM REC 2007;6:320-32. [PMID: 17304519 DOI: 10.1002/tcr.20096] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
17
Deroure B, Charpentier B, Saliba F, Dürrbach A. Néphrotoxicité de l'amphotéricine B : mise au point. J Mycol Med 2006. [DOI: 10.1016/j.mycmed.2006.05.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA